Kim R Tsuchimoto Monopar Therapeutics (MNPR) insider trading activity

Kim R Tsuchimoto is Chief Financial Officer of Monopar Therapeutics. Currently has a direct ownership of 50,470 shares of MNPR, which is worth approximately $36,843. The most recent transaction as insider was on Mar 31, 2024, when has been sold 4,082 shares (Common Stock) at a price of $0.68 per share, resulting in proceeds of $2,775. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.5K

13.17% 3M change

132.24% 12M change

Total Value Held $36,843

Kim R Tsuchimoto Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 31 2024	SELL Payment of exercise price or tax liability	$2,775 $0.68 p/Share	4,082 Reduced 7.48%	50,470 Common Stock
Mar 31 2024	BUY Exercise of conversion of derivative security	-	9,956 Added 15.43%	54,552 Common Stock
Jan 01 2024	SELL Payment of exercise price or tax liability	$171 $0.34 p/Share	505 Reduced 1.12%	44,596 Common Stock
Jan 01 2024	BUY Exercise of conversion of derivative security	-	1,231 Added 2.66%	45,101 Common Stock
Dec 31 2023	SELL Payment of exercise price or tax liability	$1,384 $0.34 p/Share	4,073 Reduced 8.5%	43,870 Common Stock
Dec 31 2023	BUY Exercise of conversion of derivative security	-	9,957 Added 17.2%	47,943 Common Stock
Sep 30 2023	SELL Payment of exercise price or tax liability	$2,135 $0.62 p/Share	3,444 Reduced 8.31%	37,986 Common Stock

Sep 30 2023	BUY Exercise of conversion of derivative security	-	9,956 Added 19.37%	41,430 Common Stock
Jun 30 2023	SELL Payment of exercise price or tax liability	$4,389 $0.86 p/Share	5,104 Reduced 13.95%	31,474 Common Stock
Jun 30 2023	BUY Exercise of conversion of derivative security	-	14,846 Added 28.87%	36,578 Common Stock
Mar 31 2023	SELL Payment of exercise price or tax liability	$2,560 $1.39 p/Share	1,842 Reduced 7.81%	21,732 Common Stock
Mar 31 2023	BUY Exercise of conversion of derivative security	-	5,067 Added 17.69%	23,574 Common Stock
Jan 01 2023	SELL Payment of exercise price or tax liability	$1,189 $2.37 p/Share	502 Reduced 2.64%	18,507 Common Stock
Jan 01 2023	BUY Exercise of conversion of derivative security	-	1,230 Added 6.08%	19,009 Common Stock
Dec 31 2022	SELL Payment of exercise price or tax liability	$4,898 $2.37 p/Share	2,067 Reduced 10.42%	17,779 Common Stock
Dec 31 2022	BUY Exercise of conversion of derivative security	-	5,067 Added 20.34%	19,846 Common Stock
Sep 30 2022	SELL Payment of exercise price or tax liability	$2,665 $1.52 p/Share	1,753 Reduced 10.6%	14,779 Common Stock
Sep 30 2022	BUY Exercise of conversion of derivative security	-	5,066 Added 23.46%	16,532 Common Stock
Jun 30 2022	SELL Payment of exercise price or tax liability	$7,091 $2.3 p/Share	3,083 Reduced 21.19%	11,466 Common Stock
Jun 30 2022	BUY Exercise of conversion of derivative security	-	8,913 Added 37.99%	14,549 Common Stock
Mar 31 2022	SELL Payment of exercise price or tax liability	$1,275 $2.55 p/Share	500 Reduced 8.15%	5,636 Common Stock
Mar 31 2022	BUY Exercise of conversion of derivative security	-	1,221 Added 16.6%	6,136 Common Stock
Jan 01 2022	SELL Payment of exercise price or tax liability	$1,621 $3.21 p/Share	505 Reduced 9.32%	4,915 Common Stock
Jan 01 2022	BUY Exercise of conversion of derivative security	-	1,231 Added 18.51%	5,420 Common Stock
Dec 31 2021	SELL Payment of exercise price or tax liability	$1,608 $3.21 p/Share	501 Reduced 10.68%	4,189 Common Stock

KRT

Kim R Tsuchimoto

Chief Financial Officer

Wilmette, IL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MNPR shares.

Notify only if

Value

Insider Trading

Get notified when an Monopar Therapeutics insider buys or sells MNPR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Monopar Therapeutics

Track Activities on MNPR

Account